Table 1.
Pretreatment characteristics and treatment variables of 119 analyzable patients on NRG Oncology Radiation Therapy Oncology Group protocols 9906 and 0233
| Characteristic | T0 (n=101) | Tis/Ta (n=18) | P * |
|---|---|---|---|
| Pretreatment characteristics | |||
| Age (y) | |||
| Median | 65 | 70 | |
| Range | 41-90 | 36-82 | |
| Q1-Q3 | 59-71 | 60-78 | |
| Gender | 1.0 | ||
| Male | 89 (88) | 16 (89) | |
| Female | 12 (12) | 2 (11) | |
| Zubrod performance score | .29 | ||
| 0 | 96 (95) | 16 (89) | |
| 1 | 5 (5) | 2 (11) | |
| Clinical T stage | 1.0 | ||
| cT2 | 94 (93) | 17 (94) | |
| cT3-cT4 | 7 (7) | 1 (6) | |
| Treatment variables | |||
| Maximal complete | .59† | ||
| TURBT | |||
| Yes | 93 (97) | 18 (100) | |
| No | 3 (3) | 0 (0) | |
| Unknown | 5 | 0 | |
| Days elapsed between completing induction chemo-RT and cystoscopic evaluation/biopsy | .47‡ | ||
| Mean | 28.5 | 30.3 | |
| Median | 28 | 28 | |
| Minimum | 15 | 14 | |
| Maximum | 51 | 57 |
Abbreviations: Q1 = first quartile; Q3 = third quartile; RT = radiation therapy; TURBT = transurethral resection of bladder tumor.
Values in parentheses are percentages.
*
Fisher's exact test is used.
†
Compares yes versus no only.
‡
t test is used.